Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Shares Outstanding (2019 - 2026)

Viatris (VTRS) posted Shares Outstanding (Entity) of $1.1 billion for Q2 2026, down 1.37% on a QoQ basis from $1.2 billion in Q1 2026, and down 1.48% year-over-year from $1.2 billion in Q2 2025.

Analysis

Viatris (VTRS) Shares Outstanding (2019 - 2026) Analysis & Trends

Viatris has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $1.1 billion in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) fell 1.48% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 1.48% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 3.54% from the prior year.
  • Shares Outstanding (Entity) was $1.1 billion for Q2 2026 at Viatris, down from $1.2 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $1.2 billion in Q3 2022, with the low at $1.1 billion in Q2 2026.
  • Average Shares Outstanding (Entity) over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) increased 0.52% in 2024, then dropped 3.54% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $1.2 billion in 2022, then dropped by 0.77% to $1.2 billion in 2023, then gained by 0.52% to $1.2 billion in 2024, then slipped by 3.54% to $1.2 billion in 2025, then decreased by 0.24% to $1.1 billion in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $1.1 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 1.17 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 1.16 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 832.44 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 319.20 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 375.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 289.73 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 21.16 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 43.64 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 34.55 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 259.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Bn
Mar 31, 2026 1.16 Bn
Dec 31, 2025 1.16 Bn
Sep 30, 2025 1.16 Bn
Jun 30, 2025 1.17 Bn
Mar 31, 2025 1.19 Bn
Dec 31, 2024 1.19 Bn
Sep 30, 2024 1.19 Bn
Jun 30, 2024 1.19 Bn
Mar 31, 2024 1.20 Bn
Dec 31, 2023 1.20 Bn
Sep 30, 2023 1.20 Bn
Jun 30, 2023 1.20 Bn
Mar 31, 2023 1.20 Bn
Dec 31, 2022 1.21 Bn
Sep 30, 2022 1.21 Bn
Jun 30, 2022 1.21 Bn
Mar 31, 2022 1.21 Bn
Dec 31, 2021 1.21 Bn
Sep 30, 2021 1.21 Bn